PMID- 17992688 OWN - NLM STAT- MEDLINE DCOM- 20080321 LR - 20211020 IS - 0887-4476 (Print) IS - 1098-2396 (Electronic) IS - 0887-4476 (Linking) VI - 62 IP - 2 DP - 2008 Feb TI - (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats. PG - 110-21 AB - (+)-Methamphetamine (MA) administered on postnatal days (P) 11-15 (four times/day) results in increased corticosterone that overlaps the stress hyporesponsive period (SHRP; P2-14) and leads to later learning and memory deficits. Elevated corticosterone during the SHRP results in neurotrophin changes and long-term effects on learning. We determined whether two known stressors could mimic the effects of MA [10 (mg/kg)/dose] administration in neonatal rats. Stressors were four 15-min sessions of forced swim or isolation (confinement in forced swim tubes without water). Saline and weighed-only controls were included and all five treatments were represented within each litter. Corticosterone in plasma and brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in neostriatum and hippocampus were examined after one or four treatments on P11 or P15 (0.5, 1.75, 6.5, or 24 h after first dose). MA increased corticosterone and BDNF; forced swim and isolation also increased corticosterone, but to a lesser extent than MA, and neither stressor increased BDNF. NGF was unaffected by saline treatment, but there was a minor reduction in NGF in the forced swim group compared with the weighed-only group. The data show that MA is more potent at releasing corticosterone and increasing BDNF than short-term, repeated episodes of forced swim or isolation. The possible relationship between these changes and the long-term cognitive effects of developmental MA administration are discussed. CI - (c) 2007 Wiley-Liss, Inc. FAU - Grace, Curtis E AU - Grace CE AD - Division of Neurology, Cincinnati Children's Research Foundation, Cincinnati, Ohio 45229-3039, USA. FAU - Schaefer, Tori L AU - Schaefer TL FAU - Herring, Nicole R AU - Herring NR FAU - Skelton, Matthew R AU - Skelton MR FAU - McCrea, Anne E AU - McCrea AE FAU - Vorhees, Charles V AU - Vorhees CV FAU - Williams, Michael T AU - Williams MT LA - eng GR - K01 DA014269-05/DA/NIDA NIH HHS/United States GR - T32 ES007051-33/ES/NIEHS NIH HHS/United States GR - DA006733/DA/NIDA NIH HHS/United States GR - K01 DA014269/DA/NIDA NIH HHS/United States GR - T32 ES007051/ES/NIEHS NIH HHS/United States GR - ES07051/ES/NIEHS NIH HHS/United States GR - R01 DA006733/DA/NIDA NIH HHS/United States GR - DA014269/DA/NIDA NIH HHS/United States GR - R01 DA006733-17/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Synapse JT - Synapse (New York, N.Y.) JID - 8806914 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Central Nervous System Stimulants) RN - 44RAL3456C (Methamphetamine) RN - W980KJ009P (Corticosterone) SB - IM MH - Age Factors MH - Analysis of Variance MH - Animals MH - Animals, Newborn MH - Body Weight/drug effects MH - Brain/*drug effects/metabolism MH - Brain-Derived Neurotrophic Factor/*metabolism MH - Central Nervous System Stimulants/*administration & dosage MH - Corticosterone/*blood MH - Female MH - Male MH - Methamphetamine/*administration & dosage MH - Rats MH - Rats, Sprague-Dawley MH - Social Isolation MH - Stress, Psychological/blood/etiology/*pathology MH - Swimming MH - Time Factors PMC - PMC2744944 MID - NIHMS137150 EDAT- 2007/11/10 09:00 MHDA- 2008/03/22 09:00 PMCR- 2009/09/16 CRDT- 2007/11/10 09:00 PHST- 2007/11/10 09:00 [pubmed] PHST- 2008/03/22 09:00 [medline] PHST- 2007/11/10 09:00 [entrez] PHST- 2009/09/16 00:00 [pmc-release] AID - 10.1002/syn.20470 [doi] PST - ppublish SO - Synapse. 2008 Feb;62(2):110-21. doi: 10.1002/syn.20470.